This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aetiology

Authoring team

  • Bardet-Biedl syndrome is a genetic condition that is occurs more commonly in inbred populations and as a result of consanguineous relationships
    • there are eleven gene loci that have been identified as being significant aetiological factors in the development of the syndrome. The Bardet-Biedl syndrome gene loci (BBS) are numbered 1-11 and they appear to encode proteins involved with cilia function, microtubule organisation, cell transport and cell division
    • the most commonly identified gene loci are BBS1 and BBS 10 accounting for 23-56% and 20% of cases respectively. The next most common are BBS2 and BBS6 accounting for 8-16% and 4-5% respectively. The remaining gene loci contribute less than 4% each and it is likely that other gene loci are yet to be discovered. (1)
    • mode of inheritance of this syndrome follows a roughly autosomal recessive pattern, although recent research suggests a triallelic mode of inheritance. (2)
    • in some pedigrees there are individuals who are homozygous at one BBS gene loci and do not exhibit the phenotype. In addition to this there are pedigrees in which there are three mutations; with the individual being homozygous one BBS gene loci and heterozygous at another. These individuals do display the full genetic phenotype. It is therefore clear that the inheritance of BBS does not follow a simple Mendelian inheritance pattern. (3)

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.